A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts
ConclusionsThis protocol can provide high contrast images of tumors expressing ER or HER2 within 3 days from injection of 4FMFES to final scan of89Zr-T and, hence, provides a basis for future dual-tracer combinations that include antibodies.
Source: EJNMMI Research - Category: Radiology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin | PET Scan | Radiology | Study